Financial Consulate’s Aerie Pharmaceuticals AERI Stock Holding History

Financial Consulate’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,500	Closed	-$124K	–	116
2020 Q3	$124K	Hold	10,500	–	–	0.06%	98
2020 Q2	$155K	Hold	10,500	–	–	0.08%	94
2020 Q1	$142K	Hold	10,500	–	–	0.08%	91
2019 Q4	$254K	Hold	10,500	–	–	0.11%	89
2019 Q3	$202K	Hold	10,500	–	–	0.09%	97
2019 Q2	$310K	Hold	10,500	–	–	0.14%	76
2019 Q1	$499K	Hold	10,500	–	–	0.23%	67
2018 Q4	$379K	Hold	10,500	–	–	0.23%	72
2018 Q3	$646K	Hold	10,500	–	–	0.37%	55
2018 Q2	$709K	Hold	10,500	–	–	0.36%	54
2018 Q1	$570K	Hold	10,500	–	–	0.3%	61
2017 Q4	$627K	Sell	10,500 -8,000	-43%	-$485K	0.32%	55
2017 Q3	$899K	Hold	18,500	–	–	0.49%	45
2017 Q2	$972K	Hold	18,500	–	–	0.57%	41
2017 Q1	$839K	Sell	18,500 -1,500	-8%	-$66.9K	0.54%	43
2016 Q4	$757K	Hold	20,000	–	–	0.55%	38
2016 Q3	$755K	Hold	20,000	–	–	0.67%	30
2016 Q2	$352K	Hold	20,000	–	–	0.27%	47
2016 Q1	$243K	Hold	20,000	–	–	0.17%	63
2015 Q4	$487K	Buy	+20,000	New	+$467K	0.35%	42

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Financial Consulate's AERI Position: Q4 2020 in Review

Financial Consulate sold out of Aerie Pharmaceuticals (AERI) in Q4 2020, closing a stake of 10,500 shares — an estimated $124K sold.

Financial Consulate first reported a position in AERI in Q4 2015 and held it in 20 quarters. The position peaked at $972K in Q2 2017. 150 funds tracked by Wall St. Rank hold AERI as of Q4 2020.

Financial Consulate reported no remaining Aerie Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Financial Consulate sold 10,500 Aerie Pharmaceuticals shares in Q4 2020, an estimated $124K.
Financial Consulate first reported a position in Aerie Pharmaceuticals in Q4 2015 and held it in 20 quarters.
Financial Consulate's Aerie Pharmaceuticals position peaked at $972K in Q2 2017.
150 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2020.

Based on Financial Consulate's 13F filing for Q4 2020, filed 29 Jan 2021.